Alalevonadifloxacin (trade name Emrok O) is an antibiotic of the
fluoroquinolone class. It is a
prodrug
A prodrug is a medication or compound that, after intake, is metabolized (i.e., converted within the body) into a pharmacologically active drug. Instead of administering a drug directly, a corresponding prodrug can be used to improve how the drug ...
of
levonadifloxacin
Levonadifloxacin (trade name Emrok) is an antibiotic drug of the fluoroquinolone class. Chemically, it is the (''S'')-enantiomer of the racemic drug nadifloxacin.
It is approved in India for the treatment of skin and soft tissue infections of ...
with increased
oral bioavailability
In pharmacology, bioavailability is a subcategory of absorption and is the fraction (%) of an administered drug that reaches the systemic circulation.
By definition, when a medication is administered intravenously, its bioavailability is 100 ...
. In India, it is approved for the treatment of infections with
Gram-positive bacteria.
References
{{antibiotic-stub
Fluoroquinolone antibiotics
Prodrugs
Carboxylic acids
Piperidines
Heterocyclic compounds with 3 rings
Esters